Delivery Order SPE2DB24D1201-SPE2DB25FJDEN

Award Date 6/25/25
Potential Completion Date 6/26/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of JATENZO 198 MG CAPSULE 120S. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,168.54 and an ultimate completion date of May 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, with a firm fixed price of $3,365.22 and a period of performance through May 16, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug product JATENZO 237 MG CAPSULE 120S. The award has a ceiling value of $1,131.87 and a completion date of June 5, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JATENZO 237 MG CAPSULE 120S, a prescription medication. The contract has a firm fixed price of $2,406.07 and a performance period ending on May 14, 2025. The contract is not set aside and was awarded on May 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication JATENZO 237 MG CAPSULE 120S. The contract has a ceiling value of $2,263.74 and is a firm fixed price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of JATENZO 158 MG CAPSULE 120S. The contract has a firm fixed price of $2,555.97 and an ultimate completion date of October 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JATENZO 237 MG CAPSULE 120S. The contract has a ceiling value of $1,131.87 and a period of performance through June 6, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,217.27, is for the supply of JATENZO 158 MG CAPSULE 120S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 13, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This is a $3,401.72 delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of JATENZO 237 MG CAPSULE 120S, a medical product, to support federal medical procurement needs. The contract has a firm fixed price pricing type and an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $1,598.35 and a completion date of March 28, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJDEN
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JATENZO 237 MG CAPSULE 120S, a medical product, with a ceiling value of $3,949.27 and a period of performance through June 26, 2025. The contract is a firm fixed-price type and is not set aside for any particular business size or socioeconomic category.

Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/24/25, 11:04 AM